Interleukin 6 (humanclone HGF15 protein moiety reduced), 1-(1-L-alanyl-L-proline)-, cyclic (44®50),(73®83)-bis(disulfide) (9CI) (143631-61-2)
Identification |
Properties |
Safety Data |
|
|
Other Product
- Plasminogen activator(human tissue-type 2-chain form), 84-L-serine-, cyclic (6®36),(34®43),(51®73),(56®62),(75®83),(92®173),(113®155),(144®168),(180®261),(201®243),(232®256)-undecakis(disulfide), cyclic(32'®48'),(40'®109'),(134'®209),(166'®182'),(199'®227')-pentakis(disulfide), cyclic(264®120')-disulfide
- Interleukin 2 (humanclone pTIL2-21a protein moiety reduced) (9CI)
- Interleukin 2 (humanclone pTG853 protein moiety reduced) (9CI)
- Interleukin 2 (humanclone pTIL2-21a protein moiety reduced) (9CI)
- Neuropeptide F 1(Locusta migratoria reduced), bimol. cyclic (1®6'),(6®1')-bis(disulfide) (9CI)
- L-Valine,N-(2-quinoxalinylcarbonyl)-L-seryl-L-alanyl-L-cysteinyl-, bimol. (4®1'),(4'®1)-dilactone, cyclic (3®3')-disulfide (9CI)
- L-Valine,N-9-acridinyl-D-seryl-L-alanyl-L-cysteinyl-, bimol. (4®1'),(4'®1)-dilactone, cyclic (3®3')-disulfide (9CI)
- L-Valine,N-(2-quinoxalinylcarbonyl)-D-seryl-L-alanyl-N-methyl-L-cysteinyl-, (4®1'),(4'®1)-dilactone, cyclic (3®3')-disulfide (9CI)
- L-Phenylalaninamide,L-cysteinyl-L-tyrosyl-L-norleucylglycyl-L-tryptophyl-L-cysteinyl-L-a-aspartyl-, cyclic (1®6)-disulfide (9CI)
- L-Cysteine,L-cysteinyl-L-leucyl-L-a-glutamyl-L-a-glutamyl-L-prolyl-,cyclic (1®6)-disulfide (9CI)
- L-Cysteinamide,L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-, cyclic (1®6)-disulfide (9CI)
- L-Cysteine,S-[2,3-bis[(1-oxohexadecyl)oxy]propyl]-N-(1-oxohexadecyl)-L-cysteinyl-L-seryl-L-asparaginyl-L-seryl-L-tryptophylglycyl-L-cysteinyl-L-alanyl-L-phenylalanyl-L-arginyl-L-glutaminyl-L-valyl-,cyclic (7®13)-disulfide (9CI)
- Substance P,3-L-cysteine-6-L-cysteine-8-L-tyrosine-9-L-proline-, cyclic (3®6)-disulfide (9CI)
- L-Cysteine,N-acetyl-L-cysteinyl-L-histidyl-L-serylglycyl-L-tyrosyl-L-valylglycyl-L-alanyl-L-arginyl-,methyl ester, cyclic (1®10)-disulfide (9CI)
- L-Cysteine,N-[(1,1-dimethylethoxy)carbonyl]-L-cysteinylglycyl-L-prolylglycyl-L-prolyl-,diphenylmethyl ester, cyclic (1®6)-disulfide (9CI)
- Glycinamide,N-[(1-mercaptocyclohexyl)acetyl]-D-isoleucyl-L-phenylalanyl-L-alanyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-arginyl-,cyclic (1®5)-disulfide (9CI)
- Phosphoprotein (humanclone 5 interleukin 2-stimulated precursor protein moiety reduced) (9CI)
- L-Methioninamide,L-cysteinyl-L-asparaginyl-L-cysteinyl-L-lysyl-L-alanyl-L-prolyl-L-a-glutamyl-L-threonyl-L-lysyl-L-leucyl-L-cysteinyl-L-arginyl-L-methionyl-L-leucyl-L-cysteinyl-L-phenylalanyl-L-lysyl-L-phenylalanyl-L-tyrosyl-,cyclic (1®11),(3®15)-bis(disulfide) (9CI)
- 1-223-Colony-stimulatingfactor 1 (human clone p3ACSF-69 protein moiety), cyclic (7®90),(48®139),(102®146)-tris(disulfide), bimol.cyclic (31®31'),(157®157'),(159®159')-tris(disulfide)
- L-Cysteine,L-cysteinyl-L-tyrosyl-L-alanyl-L-alanyl-L-prolyl-L-leucyl-L-lysyl-L-prolyl-L-alanyl-L-lysyl-L-seryl-,cyclic (1®12)-disulfide (9CI)